Blog posts


Commission omission

Medicines information in the EU may look different in the near future, but only after we see the European Commission’s long-awaited research paper on the shortcomings of product information. Technically due in January last year, and then “expected" in summer 2013, the EC document – mandated by the recent pharmacovigilance directive – has yet to be published. To judge by the consultation surveys, there could be radical changes to the way we talk to medicines users – e-labelling is much talked about these days, and summary headlines in product information featured strongly in the research (led by Dutch institute NIVEL). See further notes below, and watch this space: http://ec.europa.eu/health/human-use/information-to-patient/legislative-developments_en.htm

This post has been updated.